Anchor Investment Management LLC Sells 875 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Anchor Investment Management LLC reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,453 shares of the exchange traded fund’s stock after selling 875 shares during the period. Anchor Investment Management LLC’s holdings in SPDR S&P Biotech ETF were worth $539,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ORG Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth $40,000. Envestnet Portfolio Solutions Inc. purchased a new position in SPDR S&P Biotech ETF in the second quarter worth about $290,000. Brookstone Capital Management grew its position in SPDR S&P Biotech ETF by 541.9% in the second quarter. Brookstone Capital Management now owns 19,205 shares of the exchange traded fund’s stock worth $1,917,000 after acquiring an additional 16,213 shares in the last quarter. Meridian Investment Counsel Inc. increased its stake in SPDR S&P Biotech ETF by 8.9% during the second quarter. Meridian Investment Counsel Inc. now owns 15,537 shares of the exchange traded fund’s stock worth $1,440,000 after acquiring an additional 1,275 shares during the last quarter. Finally, Means Investment CO. Inc. raised its position in SPDR S&P Biotech ETF by 56.4% during the second quarter. Means Investment CO. Inc. now owns 104,942 shares of the exchange traded fund’s stock valued at $9,729,000 after purchasing an additional 37,847 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $93.40 on Friday. The firm has a market capitalization of $7.12 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a 50 day simple moving average of $98.05 and a 200-day simple moving average of $97.01. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.